← Browse by Condition
Medical Condition
carcinoma pancreatic ductal
Total Trials
2
Recruiting Now
2
Trial Phases
Various
NCT05475366
Recruiting
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
Enrollment
85 pts
Location
France
Sponsor
Institut Curie
NCT05461430
Recruiting
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Enrollment
200 pts
Location
United States
Sponsor
Travera Inc